Institution identification

PURI

https://redirect.ema.europa.eu/resource/41252

Institution ID

41252

Institution full name and acronym

Evidence and Access/Analytica Laser, Certara

Institution countries

France
United Kingdom (Northern Ireland)

Type of institution

Non-Pharmaceutical company

Institution website

ENCePP partner

Yes
Institution description
Certara is an organization advancing modern, efficient drug development and provides modeling & simulation, regulatory and real-world value assessment software platforms and services. Certara (previously Analytica Laser) leverages electronic health care databases (EHCD) and electronic Medical Records (EMR) as well as its own data resource PGRx for studies in comparative effectiveness and relative risk, market access studies and bridging-to-real life studies as well as Other advanced pharmaco-epidemiological research. Certara also links observational studies to advanced modeling in so-called access data platforms built for bridging-to-real life studies. Certara studies aim to determine (not limited to):- Impact of medicines and health technologies on drug and resource utilization- Comparative/relative effectiveness of medicines & health technologies- Relative risk and continuous benefit-risk of pharmaceuticals
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact